Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
RE

REGN

Market Closed

Regeneron Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnology
US
15.41K employees
CEO: Leonard S. Schleifer
Founded: 1991
$776.84
+$0.00(+NaN%)
Market Cap
80.03B
Beta
0.24
52W Range
N/A
Dividend Yield
0.47%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Overall Sentiment
43%
Neutral
Based on 1 of 3 sources
News
42.86%
Social
--
Analyst
--
News Media
Overall Score42.86%
Positive Articles3
Neutral Articles0
Negative Articles4
Total Coverage7 articles
Social Media
No social media data available
Wall Street Analysts
No analyst recommendation data available
Social Sentiment & Market Signals
Real-time social media buzz and conversation analysis

No social sentiment data available

Social media conversation data will appear here once loaded

News Sentiment Risk Analysis
Market sentiment and news coverage impact assessment
Total Articles
7
Avg Sentiment
-0.104

Negative

Positive News
42.9%
Negative News
57.1%

Sentiment Distribution & Risk Assessment

Coverage:Low
Trend:Negative
Positive
42.9%
Neutral
0.0%
Negative
57.1%
NEGATIVEBased on 7 articles

Recent Headlines Impact

No recent news headlines available
Analyst Recommendations
Wall Street analyst consensus and rating distribution

No Analyst Data Available

Analyst recommendations are not available for this stock

Explore REGN

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

REGN in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →